Cabaletta Bio, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cabaletta Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • Cabaletta Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$33M, a 77% decline year-over-year.
  • Cabaletta Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$115M, a 68.8% decline year-over-year.
  • Cabaletta Bio, Inc. annual Operating Income (Loss) for 2023 was -$74.7M, a 37.9% decline from 2022.
  • Cabaletta Bio, Inc. annual Operating Income (Loss) for 2022 was -$54.1M, a 16.9% decline from 2021.
  • Cabaletta Bio, Inc. annual Operating Income (Loss) for 2021 was -$46.3M, a 36.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$74.7M -$20.5M -37.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$54.1M -$7.83M -16.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$46.3M -$12.5M -36.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 -$33.8M -$15.2M -81.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 -$18.7M -$12.5M -202% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$6.19M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.